Skip to main content
The effects of low-dose IL-2 on Treg adoptive cell therapy in patients with Type 1 diabetes.
SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine.
MYH9 facilitates autoregulation of adipose tissue depot development.
Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas.
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice.
Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis.
Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes.
Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults.
Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.
SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation.